The European Medicine’s Agency (EMA) medical terms simplifier contains plain-language descriptions of medical terms commonly used in information about medicines. This resource is continually reviewed and updated internally, and the EMA publishes updates periodically. Check the EMA medical terms simplifier at this link
European Medicine’s Agency (EMA) medical terms simplifier Read Post »
On October 14, 2022, the European Medicines Agency (EMA) announced that it has recommended a marketing authorisation in the EU for Ebvallo (tabelecleucel), a medicine used to treat adults and children from 2 years of age who, after receiving an organ, or a bone marrow-transplantation, develop a blood cancer called Epstein-Barr virus positive post-transplant lymphoproliferative disease
The European Medicines Agency (EMA) engagement framework aims to Facilitate participation of patients and consumers in regulatory activities all along the entire lifecycle of medicines; Foster the development of guidance and methodologies to increase collection and use of relevant patient experience data in the context of regulatory decision making; Ensure that patients, consumers and their
